Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,556.00    -63.00 (-2.41%)
Bid:
2,566.00
Ask:
2,569.00
Spread: 3.00 (0.117%)
Market Cap: £22.82b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Block listing Return

16 Jan 2026 11:41

RNS Number : 2707P
Experian plc
16 January 2026
 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 16 January 2026

 

Name of applicant:

Experian plc

Name of scheme:

The Experian UK Tax-Qualified Sharesave Plan

Period of return:

From:

18 September 2025

To:

16 January 2026

Balance of unallotted securities under scheme(s) from previous return:

833,612

 

Plus: The amount by which the block scheme has been increased since the date of the last return (if any increase has been applied for):

0

Less: Number of securities issued/allotted under scheme during period (see LR3.5.7G):

81,305

 

Equals: Balance under scheme not yet issued/allotted at end of period:

752,307

 

 

Name of applicant:

Experian plc

Name of scheme:

The Experian International Sharesave Plan

Period of return:

From:

18 September 2025

To:

16 January 2026

Balance of unallotted securities under scheme(s) from previous return:

771,564

 

Plus: The amount by which the block scheme has been increased since the date of the last return (if any increase has been applied for):

98,000

Less: Number of securities issued/allotted under scheme during period (see LR3.5.7G):

75,907

 

Equals: Balance under scheme not yet issued/allotted at end of period:

793,657

 

 

 

Name of applicant:

Experian plc

Name of scheme:

The Experian Tax-Qualified Employee Share Purchase Plan

Period of return:

From:

18 September 2025

To:

16 January 2026

Balance of unallotted securities under scheme(s) from previous return:

278,213

 

Plus: The amount by which the block scheme has been increased since the date of the last return (if any increase has been applied for):

0

Less: Number of securities issued/allotted under scheme during period (see LR3.5.7G):

0

 

Equals: Balance under scheme not yet issued/allotted at end of period:

278,213

 

 

 

Name of applicant:

Experian plc

Name of scheme:

The Experian Irish Approved Sharesave Plan 

Period of return:

From:

18 September 2025

To:

16 January 2026

Balance of unallotted securities under scheme(s) from previous return:

150,340

Plus: The amount by which the block scheme has been increased since the date of the last return (if any increase has been applied for):

0

Less: Number of securities issued/allotted under scheme during period (see LR3.5.7G):

566

Equals: Balance under scheme not yet issued/allotted at end of period:

149,774

 

 

Name of contact:

Claire Murphy, Deputy Company Secretary, Experian plc

 

Telephone number of contact:

+353 (0) 87 118 4397

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRAKABBDBKDODD
Date   Source Headline
7th Feb 20249:14 amRNSAdditional Listing
6th Feb 20243:47 pmRNSDirector/PDMR Shareholding
31st Jan 202410:00 amRNSTotal Voting Rights
31st Jan 20249:20 amRNSAdditional Listing
24th Jan 20249:47 amRNSAdditional Listing
17th Jan 202412:44 pmRNSDirector/PDMR Shareholding
17th Jan 20249:44 amRNSAdditional Listing
16th Jan 20247:00 amRNSExperian Q3 FY24 trading update
12th Jan 20245:44 pmRNSFirst Interim Dividend
10th Jan 202410:55 amRNSAdditional Listing
3rd Jan 20249:02 amRNSAdditional Listing
29th Dec 202310:03 amRNSTotal Voting Rights
15th Dec 20239:32 amRNSElections for first interim dividend
13th Dec 20239:31 amRNSAdditional Listing
6th Dec 20239:14 amRNSAdditional Listing
30th Nov 202312:14 pmRNSTotal Voting Rights
29th Nov 20239:43 amRNSAdditional Listing
22nd Nov 20239:25 amRNSAdditional Listing
15th Nov 20237:00 amRNSHalf-year Report
10th Nov 20239:00 amRNSDirector Declaration
31st Oct 20235:04 pmRNSTransaction in Own Shares
31st Oct 202312:22 pmRNSTotal Voting Rights
30th Oct 20235:13 pmRNSTransaction in Own Shares
27th Oct 20235:32 pmRNSTransaction in Own Shares
26th Oct 20235:44 pmRNSTransaction in Own Shares
25th Oct 20235:17 pmRNSTransaction in Own Shares
24th Oct 20235:42 pmRNSTransaction in Own Shares
11th Oct 20239:46 amRNSAdditional Listing
6th Oct 20233:30 pmRNSShare repurchase programme
4th Oct 20239:04 amRNSAdditional Listing
27th Sep 20235:07 pmRNSTransaction in Own Shares
27th Sep 20239:50 amRNSAdditional Listing
26th Sep 20235:08 pmRNSTransaction in Own Shares
25th Sep 20235:47 pmRNSTransaction in Own Shares
20th Sep 20239:13 amRNSAdditional Listing
19th Sep 20232:45 pmRNSBlock listing Interim Review
13th Sep 20239:30 amRNSAdditional Listing
31st Aug 202312:32 pmRNSTotal Voting Rights
30th Aug 20239:25 amRNSAdditional Listing
23rd Aug 20235:34 pmRNSTransaction in Own Shares
23rd Aug 20239:32 amRNSAdditional Listing
22nd Aug 20235:54 pmRNSTransaction in Own Shares
16th Aug 20239:16 amRNSAdditional Listing
9th Aug 20239:30 amRNSAdditional Listing
2nd Aug 20239:16 amRNSAdditional Listing
31st Jul 202312:05 pmRNSTotal Voting Rights
26th Jul 202310:00 amRNSAdditional Listing
25th Jul 20232:30 pmRNSDirector/PDMR Shareholding
25th Jul 202310:30 amRNSDirector/PDMR Shareholding
19th Jul 20232:32 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.